BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30
• 31

• Pharm Country

  EnGeneIC Pty Ltd Receives FDA Orphan Drug Designation For Targeted EDV Nanocells To Treat Glioblastoma Multiforme

  March 2, 2017

   · 

  2 min read
• Business

  PureTech Appoints Bharatt Chowrira, Ph.D., J.D., As President And Chief Of Business And Strategy

  March 2, 2017

   · 

  4 min read
• BioMidwest

  EXACT Sciences And Mayo Clinic Study Shows Promise Of New Blood-Based Lung Cancer Test

  March 2, 2017

   · 

  6 min read
• Business

  ASPiRA LABS Announces Contracted In-Network Agreement With Blue Cross Blue Shield Of Michigan For OVA1

  March 2, 2017

   · 

  6 min read
• Drug Development

  PTC Therapeutics Announces Results From Pivotal Phase III Clinical Trial Of Ataluren In Patients Living With Nonsense Mutation Cystic Fibrosis

  March 2, 2017

   · 

  8 min read
• Drug Development

  Myovant Initiates Phase III Clinical Trial Of Relugolix In Men With Advanced Prostate Cancer

  March 2, 2017

   · 

  5 min read
• Drug Development

  Chugai Pharma’s Anti-IL-31 Receptor A Humanized Monoclonal Antibody “Nemolizumab (CIM331)” Global Phase II Study Data Published In The New England Journal of Medicine Online

  March 2, 2017

   · 

  4 min read
• Drug Development

  GlycoMimetics, Inc. To Present New Preclinical Data In Multiple Myeloma At AACR Annual Meeting 2017

  March 2, 2017

   · 

  4 min read
• U.S. Med Device Firm Visioneering Technologies to List On ASX

  March 2, 2017

   · 

  5 min read
• Business

  Antibe Therapeutics Reports Q3 2017 Interim Financial And Operating Results

  March 2, 2017

   · 

  3 min read